1. Home
  2. AMRK vs ARCT Comparison

AMRK vs ARCT Comparison

Compare AMRK & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo A-Mark Precious Metals Inc.

AMRK

A-Mark Precious Metals Inc.

HOLD

Current Price

$29.25

Market Cap

672.1M

Sector

Industrials

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$7.13

Market Cap

194.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRK
ARCT
Founded
1965
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
672.1M
194.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AMRK
ARCT
Price
$29.25
$7.13
Analyst Decision
Buy
Buy
Analyst Count
3
11
Target Price
$33.00
$38.67
AVG Volume (30 Days)
351.3K
943.4K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
2.73%
N/A
EPS Growth
N/A
N/A
EPS
0.30
N/A
Revenue
$11,944,284,000.00
$97,601,000.00
Revenue This Year
$1.32
N/A
Revenue Next Year
$8.68
N/A
P/E Ratio
$96.11
N/A
Revenue Growth
20.29
N/A
52 Week Low
$19.39
$5.85
52 Week High
$30.50
$24.17

Technical Indicators

Market Signals
Indicator
AMRK
ARCT
Relative Strength Index (RSI) 66.79 37.15
Support Level $25.48 $6.07
Resistance Level $27.31 $6.90
Average True Range (ATR) 1.07 0.42
MACD 0.37 0.41
Stochastic Oscillator 95.57 80.27

Price Performance

Historical Comparison
AMRK
ARCT

About AMRK A-Mark Precious Metals Inc.

A-Mark Precious Metals Inc is a precious metal trading company. It is principally engaged in the wholesale of gold, silver, platinum, copper, and palladium bullion and related products in the form of bars, wafers, coins, and grains. The company's operating segment includes Wholesale Sales & Ancillary Services; Secured Lending; and Direct-to-Consumer. It generates majority of its revenue from the Wholesale Trading and Ancillary Services segment. The Wholesale Trading and Ancillary Services segment comprises business units such as Industrial, Coin and Bar, Trading and Finance, Storage, Logistics, and Mint. Geographically, it derives a majority of its revenue from the United States and the rest from Europe, Asia Pacific, Africa, Australia, Canada, South America, and Asia Pacific.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: